Gut
Health
Acute and Chronic
Gastrointestinal Tract Disease
Due to the specific binding activity and complementary action against
Gastrointestinal pathogens by the colostrum, products may be targeted
towards the treatment of Acute and Chronic Gastrointestinal Disease.
These are conditions such as:
Gastric ulcers
Duodenal ulcers
Ulcerative colitis
(known as Inflammatory bowel disease)
Crohn's disease
( also referrred to as Inflammatory bowel disease)
Chronic diverticulosis
Irritable bowel
disease (IBS)
Pseudomembranous
colitis
Antibiotic associated
diarrhoea
Travellers diarrhoea
(caused by enterotoxigenic E. coli)
Juvenile diarrhoea
Cryptosporidiosis
associated diarrhoea
Overview of the
Gastrointestinal Tract
Infection of the Gastrointestinal Tract (GIT) is a very common occurrence.
The GIT can be infected with bacterial, yeast and parasitic pathogens
which can evoke an acute infection such as a passing gastroenteritis,
or a chronic infection resulting in a chronic disability often characterised
by diarrhoea, cramping, urgency, flatulence, nausea and vomiting.
Acute infections can be self-limiting.
For example, Salmonella, Shigella and acute viral infections can be
transient and the body's immune system and the bowel flora are able
to remove the infective agent. Other infections, such as Campylobacter
jejuni, Clostridium difficile and Yersinia enterocolitica can cause
infections that last for months or even years.
In many situations, such infections can also be cleared from the GIT
by the body's own immune system and by the surrounding bacterial flora
whose role - in part - it is to remove such infecting bacterial and
parasitic pathogens from the GIT.
However, in other situations, some pathogens, for example Yersinia
enterocolitica, Helicobacter pylori can enter the bowel flora and
establish themselves so they are permanently in the bowel.
The infected GIT therefore requires assistance in ridding itself of
such infection. As the binding studies have shown, Colostrum may provide
a helpful protective effect to the GIT due to the specific activity
against the range of bacterial and yeast pathogens responsible for
these GIT diseases.
Articles
26
